Targeting the purinergic P2X7 receptor in epilepsy: Cell types matter.

Saved in:
Bibliographic Details
Title: Targeting the purinergic P2X7 receptor in epilepsy: Cell types matter.
Authors: Engel T; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland; FutureNeuro, Research Ireland Centre for Chronic and Rare Neurological Diseases, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland. Electronic address: tengel@rcsi.ie., Salari V; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland; FutureNeuro, Research Ireland Centre for Chronic and Rare Neurological Diseases, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland., Sun MJ; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland., Mitra M; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland; FutureNeuro, Research Ireland Centre for Chronic and Rare Neurological Diseases, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland.
Source: Neuropharmacology [Neuropharmacology] 2026 Aug 15; Vol. 294, pp. 110973. Date of Electronic Publication: 2026 Apr 15.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7064
DOI:10.1016/j.neuropharm.2026.110973